Ky State Fair Screenings
Where: South Wing Health Horizons
When: August 14 - 19, 2014*
*Black out date August 18th
Cost: FREE
Who Is At Risk
Click Here to Read More
Other than skin cancer, prostate cancer is the most common cancer in American men. The American Cancer Society’s estimates for prostate cancer in the United States for 2014 are:
About 233,000 new cases of prostate cancer will be diagnosed
About 29,480 men will die of prostate cancer
Upcoming Events
Governor Beshear to Kick Off Cancer Screening
Opportunities at State Fair
Louisville, Ky. —The 2014 Kentucky State Fair will begin with a press conference to kick-off the annual Free Prostate Cancer Screenings in the South Wing Health Horizons area of the fair on August14, 2014 at 9:30am. Governor Beshear will join the Kentucky Prostate Cancer Coalition, the Kentucky Cancer Program, and KentuckyOne Health to help kick off the free cancer screening opportunity to attendees in an effort to reduce cancer rates in the Commonwealth.
Trending Topics
In The News
NOTE: Each page can have a different height. Control the height by placing more or less content.
Healthcare Glossary
PSA Test
The PSA (prostate-specific antigen) test is a simple blood test that measures the level of prostate-specific antigen in the blood. The PSA is a protein produced by cells in the prostate. Its primary function is to help keep the semen in a liquid form enabling the sperm to swim. The levels of PSA can rise due to a number reasons including the presence of cancer.
Digital Rectal Exam (DRE)
A DRE is a routine procedure as part of an annual physical exam with a doctor. The physician briefly feels the surface of the prostate for any abnormalities by inserting a gloved and lubricated finger into the rectum for a several seconds.
The DRE is used to help diagnose prostate cancer – even when a PSA test is not high – and for other prostate problems such as benign prostatic hyperplasia or prostatitis.
The general guidelines of PSA levels consider:
-
0 to 2.5 ng/mL is considered safe
-
2.6 to 4 ng/mL is safe in most men but talk with your doctor about other risk factors
-
4.0 to 10.0 ng/mL is suspicious and suggest the possibility of prostate cancer
-
10.0 ng/mL and above is dangerous and should be discussed with your doctor immediately
Biopsy
A procedure that allows the doctor to take a small core sample of the prostate for examination. If cancer is found, it can be staged and graded. A biopsy is reserved for men who have a high PSA based on other risk factors including age and family history. A suspicious DRE that demonstrates lumps or roughness may also dictate the need for a biopsy.